Complications after superficial parotidectomy for pleomorphic adenoma by Infante Cossío, Pedro et al.
Med Oral Patol Oral Cir Bucal. 2018 Jul 1;23 (4):e485-92.                                                                                                                                            Complications after superficial parotidectomy 
e485
Journal section: Oral Surgery
Publication Types: Research
Complications after superficial parotidectomy for pleomorphic adenoma
Pedro Infante-Cossio 1, Eduardo Gonzalez-Cardero 2, Alberto Garcia-Perla-Garcia 2, Enrique Montes-Latorre 3, 
Jose-Luis Gutierrez-Perez 4, Victoria-Eugenia Prats-Golczer 5
1 Professor, Department of Surgery, School of Medicine, University of Seville, Department of Oral and Maxillofacial Surgery, 
Virgen del Rocio University Hospital, Seville, Spain  
2 Staff Surgeon, Department of Oral and Maxillofacial Surgery, Virgen del Rocio University Hospital, Seville, Spain   
3 Staff, Department of Clinical Neurophysiology, Virgen del Rocio University Hospital, Seville, Spain   
4 Professor, Department of Stomatology, School of Dentistry, University of Seville, Department of Oral and Maxillofacial Sur-
gery, Virgen del Rocio University Hospital, Seville, Spain  
5 Staff Surgeon, Department of Oral and Maxillofacial Surgery, Torrejon University Hospital, Madrid, Spain
Correspondence:
Department of Oral and Maxillofacial Surgery 
Virgen del Rocio University Hospital





Background: The significance of complications after superficial parotidectomy remains unclear, since prospec-
tive studies are lacking. The aim of this study was to evaluate facial nerve dysfunction and other postoperative 
complications after superficial parotidectomy for pleomorphic adenoma of the superficial lobe and to identify the 
associated risk factors.
Material and Methods: Prospective and descriptive clinical study on 79 patients undergoing formal superficial 
parotidectomy with the modified facelift incision, dissection of the facial nerve and reconstruction with the super-
ficial musculoaponeurotic system flap. Function of the facial nerve using the House-Brackmann scale and the in-
tra- and postoperative complications were recorded at 1 week and 1, 3, 6 and 12 months. A descriptive, inferential 
and binary logistic regression analysis were performed for the variables facial nerve dysfunction, tumor size and 
location, clinical presentation and duration of surgery.
Results: 77.2% of the patients presented facial paresis at 1 week, with the marginal-mandibular branch being the 
most commonly affected (64.5%). 94.9% recovered the facial function at 6 months and 100% at 12 months. A 
statistically significant relationship was found between the appearance of facial paresis and tumor location in the 
superior lateral area of the superficial lobe, size >2 cm and prolonged operative time. None of the remaining vari-
ables showed significant differences at any study timepoint. At 12 months, 57% of patients had recovered tactile 
sensitivity in the earlobe. The clinical occurrence of Frey’s syndrome was 11.4%.
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Introduction
Conventional treatment for pleomorphic adenoma lo-
cated in the superficial lobe of the parotid gland consists 
of a formal superficial parotidectomy to remove the tu-
mor with a clear margin preserving the facial nerve. The 
elimination of the superficial lobe ensures a very low in-
cidence of tumor recurrence, but it can cause a number 
of major and minor complications due to the dissection 
of the facial nerve and the loss of at least three quarters 
of the parotid gland volume (1). The most significant 
complication is the facial nerve dysfunction that can ap-
pear as paralysis (complete loss of function) or paresis 
(partial loss) (2,3). In most cases, this facial paresis is 
temporary and recovery of nerve function is achieved 
before 6 months after surgery, usually within the first 
two months (4,5). Other postparotidectomy complica-
tions include infection, salivary fistula, hemorrhage, he-
matoma, sialocele/seroma, aesthetic deformity, numb-
ness around the earlobe and Frey’s syndrome (2,6-8).
Contributing factors associated with complications af-
ter superficial parotidectomy remain unclear. The inci-
dence varies considerably from one study to another, 
and in general, most of them are retrospective and lack 
standardized methods to assess postoperative compli-
cations. In recent years, some centers have advocated 
more conservative alternative procedures such as par-
tial parotidectomy and extracapsular dissection, in or-
der to limit or avoid dissection of the facial nerve and 
preserve part of the superficial lobe of the parotid gland 
(9,10). Other surgeons have used the facelift incision 
(rhytidectomy), first described for a parotidectomy by 
Appiani, using a retroauricular incision and positioning 
the cut close to the hairline to disguise the most visible 
part of the scar and thus improve the aesthetic outcomes 
(11). Several methods, such as reconstruction with the 
superficial musculoaponeurotic system (SMAS) flap, 
have been used to cover the postoperative defect after 
parotidectomy (8). In addition, the SMAS flap appears 
to prevent the occurrence of Frey’s syndrome (12).
The knowledge of the potential risks and complications 
associated with superficial parotidectomy may be rel-
evant to offer better preoperative counseling to patients, 
improve preoperative planning and achieve better long-
term results. The objective of this prospective study 
was to evaluate the facial nerve dysfunction and other 
surgical complications related to the formal superficial 
parotidectomy for pleomorphic adenoma located in the 
superficial lobe of the parotid gland, and to identify the 
possible associated risk factors.
Material and Methods
A descriptive and prospective longitudinal clinical 
study was conducted in the Department of Oral and 
Maxillofacial Surgery of the Virgen del Rocio Univer-
sity Hospital, Seville (Spain), on patients undergoing 
superficial parotidectomy with dissection of the facial 
nerve for pleomorphic adenoma located in the superfi-
cial area of the parotid gland. We excluded patients aged 
<18 years, tumors with another type of histology or with 
extension to the deep lobe, and patients with previous 
operation on the parotid gland. The study was approved 
by the hospital ethics committee and all patients gave 
their informed consent to participate.
Preoperatively, the diagnosis of pleomorphic adenoma 
was established in all cases by a combination of fine 
needle aspiration cytology and computed tomography 
or magnetic resonance imaging. All surgical procedures 
met two conditions: removal of the superficial lobe and 
dissection of the facial nerve. A modified facelift inci-
sion was designed and a SMAS flap was raised. Next, 
the main trunk of the facial nerve was identified at its 
exit from the stylomastoid foramen and all its periph-
eral branches were followed in an antegrade manner, 
while the superficial lobe was excised. When technical-
ly possible, the posterior branch of the great auricular 
nerve (GAN) was preserved. After the parotidectomy 
had been completed, the SMAS was re-approximated 
and sutured back to the anterior border of the sternoclei-
domastoid muscle, a suction drain was placed, and the 
skin incision was closed.
- Data collection. The following pre- and intraoperative 
demographic and clinical data were included: age and 
sex of patients, size and location of the tumor, mode of 
clinical presentation, duration of the operation, affected 
facial side, and preservation of the GAN. The location 
of the tumor was evaluated by dividing the superficial 
lobe into two anatomical areas: I (superior lateral) and 
II (inferior lateral) (10). Tumors located above a line 
drawn from the bifurcation of the facial nerve to the 
exit of the Stensen duct were assigned to area I, and 
Conclusions: Despite the high incidence of postoperative facial paresis at 1 week, its magnitude was low and the 
recovery time was short. Tumor location in the parotid superficial lobe upper area, size and prolonged operative time 
are risk factors that can worsen facial paresis at different study timepoints. The knowledge of these complications is 
relevant for patient ś counseling and to achieve better long-term outcomes.
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those below this line, to area II (Fig. 1). Basically, area 
I corresponded to the temporo-zygomatic branches and 
area II to the marginal-mandibular-cervical branches.
Fig. 1: Intraoperative view of areas I and II after dissection of the 
facial nerve (FN). Detail of the facial nerve and GAN dissection, 
while the superficial lobe remains attached by the Stensen duct (SD).
Postoperative complications such as facial paralysis, 
local complications (wound infection, salivary fistula, 
hemorrhage, hematoma, sialocele/seroma), numbness 
around the earlobe, aesthetic deformity, and Frey’s syn-
drome, were prospectively recorded by one of the au-
thors in follow-up visits at 1 week and 1, 3, 6 and 12 
months. The function of the facial nerve was graded 
with the House-Brackmann facial nerve grading system 
(HBFNGS). The HBFNGS is a widely validated instru-
ment (13,14) that classifies the grade of clinical paresis 
from grade I (no paresis) to grade VI (total paresis). For 
this study, it was considered that an affectation of grade 
II or above in either of the nerve branches had a clinical 
paresis of the facial nerve. An electromyography was 
performed to compare the non-paretic side with the pa-
retic side of the face. For the sensory alteration of the 
GAN, the tactile sensitivity was evaluated in the earlobe 
and pre-auricular skin, and it was graduated in 3 grades 
(no loss of sensitivity, hypoaesthesia, dysesthesia). Cu-
taneous scarring was classified into 3 categories (ideal, 
moderate, hypertrophic). The satisfaction of the patient 
with the cosmetic outcome was evaluated by means of 
an ordinal visual analog scale (VAS) (0=intolerable, 
1-3=deficient, 4-6=average, 7-9=good, 10=normal or 
very good). The deformity caused by the depression of 
the facial contour was classified in 3 grades (none, mod-
erate, major).
- Statistical analysis. 
The collected data were analyzed in SPSS for Windows 
v.19 (SPSS Inc. USA) by an independent medical statis-
tician. For descriptive statistics of qualitative variables, 
absolute and relative frequencies were used and, for 
quantitative variables, the median or interquartile range 
if they did not follow a normal distribution as assessed 
by the Kolmogorov-Smirnov test. For the qualitative 
variables, a bivariate study was performed using the 
Chi-Square test or the Fisher ś exact test, as appropri-
ate. The comparison of the quantitative variables was 
assessed using the Student’s t-test for independent 
samples and the non-parametric Mann-Whitney U-test 
if they followed an asymmetric distribution. Values of 
p<0.05 were considered significant.
Results
We included 79 patients in the study, 39 men (49.4%) 
and 40 women (50.6%), with a mean age of 48 years 
(range 24-81 years). The mean time of follow-up was 
30.65 months (range 12-45 months). Table 1 shows the 
preoperative demographic and clinical data. 65.8% % of 
tumors were located on the right side while 35.5% were 
sited in area I, 53.1% in area II, and 11.4% involved both 
superficial areas (I and II). The most common clinical 
presentation was as a slowly growing mass (84.9%). The 
mean tumor size was 2.44 cm (range 1-6 cm). The mean 
time until the patient’s first visit was 18 months (range 
Variable N of patients 
(%)
Gender Male 39 (49.4)
Female 40 (50.6)
Side of tumor Right 52 (65.8)
Left 27 (34.2)
Site of tumor 
according to facial 
nerve
Area I (superior 
lateral)
28 (35.5)
Area II (inferior 
lateral)
42 (53.1)
Both areas I + II 
(superior + inferior 
lateral)
9 (11.4)





Slow growth 67 (84.9)
Rapid growth 2 (2.5)
Size of tumor (cm) <2 33 (41.8)
>2 46 (58.2)
Table 1: Preoperative demographic and clinical characteristics of 79 
patients.
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2-180 months). The mean operative time was 154.5 min-
utes (range 85-240 minutes, SD=57.8). The median time 
of hospitalization was 2.5 days (range 1-7 days).  
According to the HBFNGS, 77.2% of the patients 
showed a grade II of involvement or above in either of 
the facial nerve branches at 1 week, 51.9% at 1 month, 
30.4% at 3 months, 5% at 6 months and 0% at 12 months 
(Table 2). The mean recovery time was 2 months (inter-
Variable N of patients (%)
1 week 1 month 3 months 6 months 12 months
Global facial paresis 61 (77.2) 41 (51.9) 24 (30.4) 4 (5.0) 0
Temporal branch 34 (43.0) 19 (24) 12 (15.2) 2 (2.5) 0
Zygomatic branch 44 (55.7) 28 (35.4) 13 (16.5) 1 (1.2) 0
Buccal branch 44 (55.7) 23 (29.1) 7 (8.9) 0 0
Marginal-mandibular 
branch
51 (64.5) 33 (41.8) 18 (22.8) 4 (5.0) 0
Cervical branch 36 (45.6) 17 (21.5) 7 (8.9) 0 0
Table 2: Paresis of the facial nerve and of each branch after superficial parotidectomy according to the HBFNGS, at each time-
point of the study.
quartile range=0.25-5.75). The paresis for each branch 
at each timepoint of the study revealed that the mar-
ginal-mandibular one was the most frequently affected 
at 1 week (64.5%) and had the highest percentage of 
affectation at all the timepoints. The paresis was 0% 
at 12 months for all branches. At 1 week, the magni-
tude of the paresis was graded as grade II in 80.3%, 
grade III in 18.1% and grade IV in 1.6%. In multivariate 
analysis, paresis of the facial nerve showed a statisti-
cally significant difference with the location of tumor in 
area I at 1 week (p=0.002) and 1 month (p=0.004), size 
of tumor >2cm at 6 months (p=0.040), and prolonged 
operative time >154.5 minutes at 1 week (p=0.016), 1 
month (p=0.002) and 3 months (p=0.018). Facial paresis 
showed no statistical relationship at any timepoint of the 
study with respect to age, sex, mode of clinical presen-
tation and affected side.
The neurophysiological study revealed a lower am-
plitude on the side of the dissected nerve in 98.3% of 
cases at 1 week (48.15% of amplitude, SD=25.9%). The 
cases without clinical paresis had a 61% of amplitude 
compared to the non-dissected side, and the cases with 
clinical paresis had a 43.5% of amplitude compared to 
the non-dissected side. The difference in amplitude be-
tween both sides was statistically significant (p=0.017). 
The neurophysiological determination revealed a com-
plete recovery of all patients at 12 months.
Table 3 shows the incidence of other complications. 
12.7% of patients presented hematoma at 1 week. The 
posterior branch of the GAN was preserved in 41 pa-
tients (51.9%). 67 patients (84.9%) exhibited a reduction 
in tactile sensitivity in the earlobe or preauricular skin 
at 1 week. At 12 months, 45 patients (57%) recovered 
the same grade of sensitivity as before surgery, and the 
rest had some grade of numbness. 61% of the patients 
in whom the GAN had been preserved and 45.6% in 
whom it had not, recovered the sensitivity, although the 
differences were not statistically significant. The recov-
ery time for those patients who recovered the sensitivity 
of the GAN at 12 months was 7.03 months (SD=4.15 
months). At 12 months, 75.9% of patients had an ideal 
scar (Fig. 2). The mean patient ś satisfaction score with 
the scar was 9 in the VAS (interquartile range=9-10). 
43% of the patients did not notice any deformity caused 
by the depression of the facial contour and 40.5% re-
ferred a moderate depression (Fig. 3). 9 patients (11.4%) 
exhibited Frey’s syndrome, although only 1 patient re-
ported symptoms without being asked specifically.
Discussion
Pleomorphic adenoma is the most common benign neo-
plasm of the parotid gland (15). It occurs most frequent-
ly between the ages of 40 and 50 years, and in women 
than in men (16). It usually appears as a slowly growing 
painless mass, with a variable time evolution, normally 
located in the caudal portion of the superficial lobe. In 
general terms, the demographic and clinical findings of 
our study confirm all these data, widely previously re-
ported in the literature.
Our findings showed that facial nerve dysfunction was 
the most common complication after superficial paroti-
dectomy for pleomorphic adenoma. Although the per-
centage of appearance of facial nerve paresis at 1 week 
was 77.2%, half of the patients recovered facial function 
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Variable N of patients (%)
1 week 12 months
Local complications Infection 0 --
Salivary fistula 0 --
Sialocele/seroma 0 --
Hemorrhage/ hematoma 10 (12.7) --
Sensitivity in earlobe 
or pre-auricular skin
Hypoesthesia 57 (72.4) 28 (35.4)
Dysesthesia 10 (12.5) 6 (7.6)
No loss 12 (15.2) 45 (57)
Scar appearance Ideal -- 60 (75.9)
Moderate -- 12 (15.2)
Hypertrophic -- 7 (8.9)
Depression of facial 
contour
None -- 34 (43.0)
Moderate -- 32 (40.5)
Major -- 13 (6.5)
Frey ś syndrome -- 9 (11.4)
Table 3: Complications after superficial parotidectomy (excluding facial nerve paresis).
Fig. 2: Scar appearance at 1 year. Ideal (left), moderate (central) or hypertrophic (right).
Fig. 3: Depression of the facial contour at 1 year. None (left), moderate (central) or major (right).
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at 1 month, 94.9% at 6 months and 100% at 12 months, 
by and large demonstrating a short recovery time. In the 
literature, the percentage of facial postoperative paresis 
varies from 10% to 70% for transient involvement, and 
from 0 to 19% for definitive involvement (1,2,17-19).
The high incidence of postoperative facial paresis in 
our study was possibly due to the fact that we consid-
ered as paresis that minimal involvement of II grade or 
above in either of the facial nerve branches according 
to the HBFNGS. Given that we recorded the data in a 
prospective manner and by specific branch, our results 
are difficult to compare because most of studies are ret-
rospective and measured the global percentage of facial 
paresis without considering the magnitude of paresis or 
the specific branch involved. The most affected branch 
at 1 week was the marginal-mandibular one (64.5%), as 
in most of the series (1,2).
Despite the high incidence of postoperative facial pare-
sis of patients at 1 week, its magnitude was low (80.3% 
had grade II according to the HBFNGS). For statistical 
analysis, the evaluation of the grade of paresis was not 
taken into account because our objective was to evalu-
ate the appearance of clinical paresis and its evolution 
in the timepoints of the study, regardless of the grade 
and the affected branch. Although the majority of tu-
mors were located in the inferior area of the superficial 
lobe (53.1%), we did not find a statistical relationship be-
tween dysfunction of the marginal-mandibular branch 
and location in the inferior lateral site. Our results sug-
gest that the location of tumor in the superior area of 
the superficial lobe, the size of tumor >2cm and the pro-
longed operative time are risk factors that can worsen 
facial paresis at different study timepoints.  
According to previous studies, several factors have 
been associated with a higher incidence of facial pare-
sis in parotid surgery (2,17,20-25): extent and type of 
surgical procedure (higher incidence in total parotidec-
tomy and greater resection of glandular tissue), patient 
age, operative time, tumor histopathology (higher inci-
dence in malignant tumors), tumor size (greater inci-
dence in large tumors) and location (higher incidence 
in deep lobe tumors), previous parotid surgery (higher 
incidence in cases of recurrent disease) and presence of 
intraglandular inflammation. The significance of these 
findings remains controversial, because some studies 
(including the present one) confirm some factors and 
others do not. On the one hand, only a few studies are 
prospective and comprise a significant number of pa-
tients with a standardized follow-up that allow the true 
assessment of facial nerve dysfunction (19). On the oth-
er hand, some studies include several tumor etiologies 
and types of parotid surgery. To minimize these biases, 
the 79 patients monitored in our study were prospec-
tively and regularly recorded, underwent the same stan-
dardized surgical operation by the same surgeons, and 
were operated on for the same condition (pleomorphic 
adenoma).
Electromyography records the spontaneous and volun-
tary muscular electrical responses caused by the elec-
trodes placed on the facial mimic muscles. It allows to 
assess the function of the facial nerve on the paretic 
side compared to the non-paretic side of the face. This 
procedure is easy, affordable and useful for the initial 
diagnosis of facial paralysis and the monitoring of long-
term recovery. In 98.3% of patients, a lower amplitude 
of nerve function was recorded on the affected side at 
1 week, which was associated with the appearance of 
clinical paresis. Our results demonstrated a statistical 
association between the amplitude of the paretic side 
and the recovery time of the paresis.
The GAN was always visualized during parotid sur-
gery, and the integrity of its posterior branch was pre-
served when viable. The true meaning of preserving 
the GAN is controversial and some authors argued that 
its preservation during parotid surgery is unnecessary 
(26). The affectation of the GAN can cause hypoesthe-
sia in the earlobe and pre-auricular skin, which inter-
feres with daily habits such as kissing, shaving or wear-
ing earrings or glasses, and an uncomfortable feeling 
when exposed to cold (27). 84.9% of the patients suf-
fered a sensory deficit at 1 week, regardless of whether 
the nerve was preserved or not, a percentage similar to 
that of other studies that report a hypoesthesia in the 
affected area despite preserving the posterior branch of 
the GAN (28). Nor did we find statistical differences in 
the recovery of tactile sensitivity depending on it would 
have been preserved or not, as reported in the literature 
(28). Min et al. (28) reported that 57% of patients recov-
ered the sensitivity at 1 year, which increased to 61% 
in patients who had the GAN preserved, figures very 
similar to ours, although they were not statistically sig-
nificant. Our findings support that the preservation of 
the posterior branch of GAN whenever possible (29,30), 
although a postoperative recovery occurs in more than 
half of the cases at 1 year, regardless of preservation 
of the GAN or not. Possibly the collateral branches are 
those that compensate this deficit, as well as the auricu-
lotemporal and occipital nerves.
The follow-up time for the evaluation of the esthetic out-
come was 12 months, enough time to ensure complete 
maturation of the scar. The modified facelift incision al-
lowed adequate access to the parotid gland to expose 
the facial nerve and identify the GAN, while achieving 
a better aesthetic outcome than the classic Blair inci-
sion once it was concealed under the hairline and folds 
of the skin and neck. The finding of 8.9% of hypertro-
phic scarring in our study is consistent with that re-
ported by other authors (31). Some degree of alteration 
of the healing process was detected in younger patients 
(mean=39.4 years) compared to the elderly (mean=49.4 
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years), although this relationship was not statistically 
significant (p=0.081). The outcome according to the pa-
tient’s perception of the appearance of the scar indicated 
a very significant satisfaction in most of them (VAS=9).
The superficial lobe comprises 70% to 80% of the vol-
ume of the parotid gland (32), so that after parotidecto-
my there is some degree of facial contour deformity that 
may compromise the aesthetic outcome. Reconstruction 
procedures such as the sternocleidomastoid muscle flap 
or SMAS flap are particularly indicated in younger pa-
tients and in defects larger than 3 cm (33,34). In our 
study, the degree of depression of the facial contour was 
not related to the tumor size (p=0.674). Despite the con-
troversy on the use of the SMAS flap following a pa-
rotidectomy, we indicated it to prevent facial depression 
and improve the contour (8). In our study, the grade of 
depression of the facial contour was classified as moder-
ate or major in 47% of the patients. De Vicente et al (12) 
investigated the modified facelift incision combined 
with an SMAS flap on patients undergoing superficial 
parotidectomy, concluding that it improved the cosmet-
ic appearance of the scar, prevented facial depression 
and reduced the incidence of Frey’s syndrome.
Frey ś syndrome is a significant complication after pa-
rotid surgery, showing an incidence that varies greatly 
from 6% to 96% (35,36). In general, it is recognized 
that approximately 10% of patients complain actively 
of Frey’s syndrome at 6 to 12 months, a percentage that 
increases to 20-30% if it is specifically investigated 
(19,37). In our study, the diagnosis was based on the 
spontaneous complaint of the patient, since our objec-
tive was to analyze the complications with clinical rel-
evance. We detected an occurrence of 11.4% of Frey’s 
syndrome. This low occurrence can be explained by the 
relatively short follow-up time of 12-month and by the 
use of the SMAS flap in all cases. Several authors have 
recommended reconstruction with a SMAS flap to re-
duce the incidence of Frey’s syndrome (11,34), although 
others have not found any differences (38). None of our 
patients required additional treatment, since the symp-
toms did not concern them in any way.
Among the main limitations of our study, we must men-
tion the lack of a control group and the relatively small 
size of the sample, since it is a single-center study, so 
the results should be interpreted with caution. The 
method we used to measure facial dysfunction was the 
HBFNGS, which although widely used and well-doc-
umented in the literature, may present intra-observer 
variations since it is a subjective scale. Finally, in future 
studies, other procedures for treatment of pleomorphic 
adenoma, such as extracapsular dissection or partial pa-
rotidectomy, could be considered for comparisons.
Conclusions
The results of our study suggest that superficial paroti-
dectomy with the modified facelift incision and recon-
struction with SMAS is a safe procedure, with few com-
plications at the long-term. Despite the high incidence 
of postoperative facial paresis at 1 week, its magnitude 
was low and the recovery time was short. The location 
of pleomorphic adenoma in the upper area of the pa-
rotid superficial lobe, the size >2cm and the prolonged 
operative time are risk factors that can worsen facial 
paresis at different study timepoints. More than half of 
the patients recovered the sensitivity of the GAN, irre-
spective of whether it was preserved or not. There was 
a low occurrence of clinical Frey ś syndrome, which 
did not require treatment. The knowledge of the poten-
tial risks and complications associated with superficial 
parotidectomy are relevant for preoperative planning, 
counseling to patients and to achieve better long-term 
outcomes. 
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